☰

Susan B. Nyland, Ph.D. - Publications

Affiliations: 
2001 University of South Florida, Tampa, FL, United States 
Area:
Immunology, Microbiology
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Nyland SB, Feith DJ, Poss M, Olson TL, Krissinger DJ, Poiesz BJ, Ruscetti FW, Loughran TP. Retroviral sero-reactivity in LGL leukaemia patients and family members. British Journal of Haematology. PMID 31608437 DOI: 10.1111/Bjh.16223  0.328
2012 Nyland SB, Krissinger DJ, Clemente MJ, Irby RB, Baab KT, Jarbadan NR, Sokol L, Schaefer E, Liao J, Cuthbertson D, Epling-Burnette P, Paquette R, List AF, Maciejewski JP, Loughran TP. Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study. Leukemia Research. 36: 581-7. PMID 22386729 DOI: 10.1016/J.Leukres.2012.02.001  0.313
2010 Yang J, Liu X, Nyland SB, Zhang R, Ryland LK, Broeg K, Baab KT, Jarbadan NR, Irby R, Loughran TP. Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway. Blood. 115: 51-60. PMID 19880494 DOI: 10.1182/Blood-2009-06-223719  0.302
2010 Nyland SB, Krissinger DJ, Clemente M, Irby RB, Baab KT, Jarbadan NR, Sokol L, Schaefer E, Liao J, Cuthbertson D, Epling-Burnette P, Paquette R, Maciejewski JP, Loughran TP. HTLV-1 Epitope (BA21) Reactivity in Rare Bone Marrow Failure Diseases Blood. 116: 1724-1724. DOI: 10.1182/Blood.V116.21.1724.1724  0.347
2009 Nyland SB, Loughran TP. Putting HIV-1 apoptosis mediators to work against cancer: A killer job, with benefits Cancer Biology and Therapy. 8: 188-191. PMID 19182513 DOI: 10.4161/Cbt.8.2.7765  0.359
2008 Zhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, Albert R, Loughran TP. Network model of survival signaling in large granular lymphocyte leukemia. Proceedings of the National Academy of Sciences of the United States of America. 105: 16308-13. PMID 18852469 DOI: 10.1073/Pnas.0806447105  0.301
2008 Clemente M, Cazzolli H, Jankowska A, O’Keefe C, Serio B, Nyland S, Wlodarski M, Epling-Burnette P, Loughran T, List A, Paquette R, Maciejewski J. Permissive Conditions for Evolution of PNH Clones Are Characterized by Overproduction of IFN-γ by Clonal CD4 and CD8 T Cells, Fas-L by CTLs, and Promoted by Immunogenetic Background Blood. 112: 4116-4116. DOI: 10.1182/Blood.V112.11.4116.4116  0.329
2006 Ugen KE, Nyland SB. Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy. Springer Seminars in Immunopathology. 28: 281-7. PMID 17109182 DOI: 10.1007/S00281-006-0045-0  0.626
2003 Nyland SB, Cao C, Bai Y, Loughran TP, Ugen KE. Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1. Journal of Acquired Immune Deficiency Syndromes (1999). 32: 406-16. PMID 12640199 DOI: 10.1097/00126334-200304010-00010  0.687
2001 Nyland SB, Specter S, Ugen KE. Direct vs. indirect modulation of complex in vitro human retroviral infections by morphine. Advances in Experimental Medicine and Biology. 493: 49-58. PMID 11727780 DOI: 10.1007/0-306-47611-8_6  0.706
1999 Nyland SB, Specter S, Ugen KE. Morphine effects on HTLV-I infection in the presence or absence of concurrent HIV-1 infection. Dna and Cell Biology. 18: 285-91. PMID 10235111 DOI: 10.1089/104454999315349  0.708
1999 Boyer JD, Chattergoon MA, Ugen KE, Shah A, Bennett M, Cohen A, Nyland S, Lacy KE, Bagarazzi ML, Higgins TJ, Baine Y, Ciccarelli RB, Ginsberg RS, MacGregor RR, Weiner DB. Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial. Clinical Immunology (Orlando, Fla.). 90: 100-7. PMID 9884357 DOI: 10.1006/Clim.1998.4616  0.653
1998 Ugen KE, Nyland SB, Boyer JD, Vidal C, Lera L, Rasheid S, Chattergoon M, Bagarazzi ML, Ciccarelli R, Higgins T, Baine Y, Ginsberg R, Macgregor RR, Weiner DB. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine. 16: 1818-21. PMID 9795386 DOI: 10.1016/S0264-410X(98)00180-7  0.693
1998 Noe SN, Nyland SB, Ugen K, Friedman H, Klein TW. Cannabinoid receptor agonists enhance syncytia formation in MT-2 cells infected with cell free HIV-1MN. Advances in Experimental Medicine and Biology. 437: 223-9. PMID 9666275 DOI: 10.1007/978-1-4615-5347-2_25  0.674
1998 Nyland SB, Specter S, Im-Sin J, Ugen KE. Opiate effects on in vitro human retroviral infection. Advances in Experimental Medicine and Biology. 437: 91-100. PMID 9666261 DOI: 10.1007/978-1-4615-5347-2_11  0.694
1998 Agadjanyan MG, Wang B, Nyland SB, Weiner DB, Ugen KE. DNA plasmid based vaccination against the oncogenic human T cell leukemia virus type 1. Current Topics in Microbiology and Immunology. 226: 175-92. PMID 9479842 DOI: 10.1007/978-3-642-80475-5_11  0.641
1997 Ugen KE, Boyer JD, Wang B, Bagarazzi M, Javadian A, Frost P, Merva MM, Agadjanyan MG, Nyland S, Williams WV, Coney L, Ciccarelli R, Weiner DB. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine. 15: 927-30. PMID 9234550 DOI: 10.1016/S0264-410X(96)00254-X  0.671
Show low-probability matches.